5-Fluorouracil and interleukin-2 immunochemotherapy enhances immunogenicity of non-small cell lung cancer A549 cells through upregulation of NKG2D ligands. | Asian Pac J Cancer Prev;15(9): 4039-44, 2014. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

5-Fluorouracil and interleukin-2 immunochemotherapy enhances immunogenicity of non-small cell lung cancer A549 cells through upregulation of NKG2D ligands.

Zhao, Lei; Wang, Wen-Jia; Zhang, Jin-Nan; Zhang, Xing-Yi.

Affiliation

Zhao L; Institute of Frontier Medical Science, Jilin University, Changchun, Jilin, China E-mail : zhang_xingyi28@163.com.

Asian Pac J Cancer Prev ; 15(9): 4039-44, 2014.

Article in En | MEDLINE | ID: mdl-24935593

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Killer Cells, Natural / Interleukin-2 / Carcinoma, Non-Small-Cell Lung / Intercellular Signaling Peptides and Proteins / Fluorouracil Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Asian Pac J Cancer Prev Journal subject: NEOPLASIAS Year: 2014 Document type: Article Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Killer Cells, Natural / Interleukin-2 / Carcinoma, Non-Small-Cell Lung / Intercellular Signaling Peptides and Proteins / Fluorouracil Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Asian Pac J Cancer Prev Journal subject: NEOPLASIAS Year: 2014 Document type: Article Country of publication: